Past Events, Networking Events, Info Session
October 12, 2017
William H. Foege Building – N130 & Main Lobby
3720 15th Ave NE
Seattle, WA 98105
BioEngage will be hosting Nanostring for an all-day visit to BIOE. Enjoy a variety of talks from key Nanostring personnel, a panel to discuss career paths, a Distinguished Lecture from Joe Beechem (Senior VP of R&D), and a reception to end the day.
**All lectures & panel take place in Foege N130
10:00AM – Presentation on current Nanostring commercialized products
Title: nCounter: Systems for Digital Molecular Counting and their Application in Biomedical Research
Presented By: Gavin Meredith PhD- Associate Director of Research & Product Development and Dwayne Dunaway PhD- Director of Engineering, Integrated Systems & Platform Research
11:30AM – Nanostring Panel to discuss career path choices with BIOE students
Panel Members: Joseph Beechem PhD- Senior Vice President of Research and Development, Gavin Meredith PhD- Associate Director of Research and Product Development, Dwayne Dunaway PhD- Director of Engineering, Integrated Systems and Platform Research, and Sarah Warren PhD- Senior Scientist, Immuno-Oncology
Lunch with BioEngage Leadership Team
1:30PM – Meetings with individual BIOE faculty & graduate students
**please email email@example.com if you are interested in setting up an individual meeting
3:00PM – Distinguished Industry Leaders Seminar: New Technologies on the Nanostring Horizon
Title: Next Generation High-Plex Optical Barcodes for Digital Spatial Profiling Microscopy and a No-Amp/No-Library Next-Generation Sequencer
Presented By: Joseph Beechem PhD- Senior Vice President of Research and Development
4:00PM – Networking Reception (Foege Lobby)
Faculty, students and staff encouraged to attend
**refreshments will be served
NanoString Technologies is a publicly held provider of life science tools for translational research and molecular diagnostics. The company’s technology enables a wide variety of basic research, translational medicine and in vitro diagnostics applications.
NanoString’s products are based on a novel digital molecular barcoding technology invented at the Institute for Systems Biology (ISB) in Seattle under direction of Dr. Leroy Hood. The company was founded in 2003 with an exclusive license to develop and market the technology. In 2008, NanoString launched its first commercial instrument system and began international sales operations with its first multiplexed assays for gene expression analysis. In 2010, the company launched new applications for the system to support microRNA analysis and copy number variation detection, and in 2013 launched Prosigna®, its first in vitro diagnostic product for prognosis of early stage breast cancer.
Organizations performing cancer research, biomarker validation and screening, and next-generation sequencing validation are rapidly adopting the nCounter® Analysis System. By providing simple, multiplexed digital profiling of single molecules, the NanoString platform represents a natural, digital downstream companion to next-generation sequencing and enables researchers to embark on studies that were previously inconceivable.
To find out more about Nanostring, please visit their website: https://www.nanostring.com/